← SynDRA
PFK-158
SynDRA canonical compound SYN0039859 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PFKFB3 |
|---|
| Mechanism of action | phosphofructokinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- phosphofructokinase inhibitor
Cross-references
Synonyms
- PFK158
- ACT-PFK-158
- RefChem:928947
- PFKFB3 Inhibitor PFK-158
- PFK-158 free base
- 2HOK1JQ203
- MFCD28386154
- UNII-2HOK1JQ203
- orb1304535
- SCHEMBL15287558
- SCHEMBL29534190
- SCHEMBL29538151
- PFK158?
- IAJOMYABKVAZCN-AATRIKPKSA-N
- EX-A2480
- MIC24975
- BDBM50422770
- s8807
- AKOS030526557
- CS-5437
- AC-35725
- BS-15437
- HY-12203
- SY326751
- N17011
- PFK158; PFK 158; PFK158; ACTPFK158
- BRD-K28010364-001-01-0
- (E)-1-pyridin-4-yl-3-[7-(trifluoromethyl)quinolin-2-yl]prop-2-en-1-one
Look up PFK-158 in the interactive SynDRA portal →